Lei‐Yun Wang

901 total citations · 1 hit paper
30 papers, 501 citations indexed

About

Lei‐Yun Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lei‐Yun Wang has authored 30 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lei‐Yun Wang's work include Genetic Associations and Epidemiology (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Lei‐Yun Wang is often cited by papers focused on Genetic Associations and Epidemiology (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (4 papers). Lei‐Yun Wang collaborates with scholars based in China, United States and Australia. Lei‐Yun Wang's co-authors include Ji‐Ye Yin, Jiajia Cui, Ding‐Chao Rong, Jie Mei, Peng‐Yuan Wang, Jun Zeng, Qian Hu, Hsuan-Shun Huang, Sai Wang and Hong‐Hao Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Optics Express.

In The Last Decade

Lei‐Yun Wang

29 papers receiving 496 citations

Hit Papers

JAK/STAT pathway: Extracellular signals, diseases, immuni... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei‐Yun Wang China 12 206 91 75 69 51 30 501
Junyong Han China 14 300 1.5× 109 1.2× 68 0.9× 111 1.6× 35 0.7× 29 570
Yukun Li China 13 299 1.5× 69 0.8× 93 1.2× 103 1.5× 98 1.9× 36 659
Shujuan Huang China 14 315 1.5× 116 1.3× 73 1.0× 99 1.4× 61 1.2× 35 699
Su Jin Kim South Korea 15 295 1.4× 146 1.6× 79 1.1× 74 1.1× 68 1.3× 38 635
Saurabh Sharma India 12 214 1.0× 54 0.6× 39 0.5× 65 0.9× 34 0.7× 35 484
Frank S Ong United States 15 274 1.3× 74 0.8× 57 0.8× 62 0.9× 108 2.1× 21 719
Peng Duan China 15 266 1.3× 120 1.3× 55 0.7× 104 1.5× 37 0.7× 31 549
Ran Wu China 13 212 1.0× 155 1.7× 62 0.8× 35 0.5× 48 0.9× 26 592
Arti Verma United States 13 289 1.4× 72 0.8× 55 0.7× 96 1.4× 83 1.6× 29 519

Countries citing papers authored by Lei‐Yun Wang

Since Specialization
Citations

This map shows the geographic impact of Lei‐Yun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei‐Yun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei‐Yun Wang more than expected).

Fields of papers citing papers by Lei‐Yun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei‐Yun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei‐Yun Wang. The network helps show where Lei‐Yun Wang may publish in the future.

Co-authorship network of co-authors of Lei‐Yun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lei‐Yun Wang. A scholar is included among the top collaborators of Lei‐Yun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei‐Yun Wang. Lei‐Yun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mei, Jie, Lei‐Yun Wang, Jun Zeng, et al.. (2025). Bronchoalveolar lavage fluid (BALF): Clinical applications for present and future. 3(1). 100115–100115.
2.
Mei, Jie, Xiaoye Zhang, Lei‐Yun Wang, et al.. (2025). Heme oxygenase 1 (HO-1) is a drug target for reversing cisplatin resistance in non-small cell lung cancer. Journal of Advanced Research. 80. 1121–1137. 4 indexed citations
3.
Rong, Ding‐Chao, Shan Chen, Hao Xu, et al.. (2025). ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions. Molecular Biomedicine. 6(1). 89–89. 2 indexed citations
4.
Mei, Jie, Ding‐Chao Rong, Raymond C.B. Wong, et al.. (2024). Anoikis in cell fate, physiopathology, and therapeutic interventions. SHILAP Revista de lepidopterología. 5(10). e718–e718. 15 indexed citations
5.
Wang, Lei‐Yun, et al.. (2023). Mendelian randomization study and meta‐analysis exploring the causality of age at menarche and the risk of intracerebral hemorrhage and ischemic stroke. CNS Neuroscience & Therapeutics. 29(10). 3043–3052. 7 indexed citations
6.
Wang, Lei‐Yun, Xingjian Liu, Ying Zhu, et al.. (2023). The romantic history of signaling pathway discovery in cell death: an updated review. Molecular and Cellular Biochemistry. 479(9). 2255–2272. 14 indexed citations
8.
Zhang, Le, et al.. (2023). Exploring the Causality of Type 1 Diabetes and Stroke Risk: A Mendelian Randomization Study and Meta-analysis. Molecular Neurobiology. 60(12). 6814–6825. 4 indexed citations
9.
Wang, Sai, Lei‐Yun Wang, Yupeng Zhang, et al.. (2023). Potential preventive markers in the intracerebral hemorrhage process are revealed by serum untargeted metabolomics in mice using hypertensive cerebral microbleeds. Frontiers in Endocrinology. 14. 1084858–1084858. 2 indexed citations
10.
Hu, Qian, Ding‐Chao Rong, Lei‐Yun Wang, et al.. (2023). JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. Frontiers in Bioengineering and Biotechnology. 11. 1110765–1110765. 174 indexed citations breakdown →
11.
Wang, Lei‐Yun, Yupeng Zhang, Junyi Ma, et al.. (2023). Promising therapeutic targets for ischemic stroke identified from plasma and cerebrospinal fluid proteomes: a multicenter Mendelian randomization study. International Journal of Surgery. 110(2). 766–776. 12 indexed citations
12.
Wang, Yang, Fan Xiao, Yi Zhao, et al.. (2022). A two-stage genome-wide association study to identify novel genetic loci associated with acute radiotherapy toxicity in nasopharyngeal carcinoma. Molecular Cancer. 21(1). 169–169. 8 indexed citations
13.
Wang, Lei‐Yun, et al.. (2022). Gut microbes in cerebrovascular diseases: Gut flora imbalance, potential impact mechanisms and promising treatment strategies. Frontiers in Immunology. 13. 975921–975921. 47 indexed citations
14.
Wang, Sai, et al.. (2021). Childhood Obesity and Risk of Stroke: A Mendelian Randomisation Analysis. Frontiers in Genetics. 12. 727475–727475. 34 indexed citations
15.
Shao, Weihua, Chengyu Wang, Lei‐Yun Wang, et al.. (2020). <p>A Hereditable Mutation of MSH2 Gene Associated with Lynch Syndrome in a Five Generation Chinese Family</p>. Cancer Management and Research. Volume 12. 1469–1482. 3 indexed citations
16.
Cui, Jiajia, et al.. (2020). The role of CSDE1 in translational reprogramming and human diseases. Cell Communication and Signaling. 18(1). 14–14. 40 indexed citations
17.
Wang, Lei‐Yun, Jiajia Cui, Junyan Liu, et al.. (2018). Gene-gene and gene-environment interaction data for platinum-based chemotherapy in non-small cell lung cancer. Scientific Data. 5(1). 180284–180284. 7 indexed citations
18.
Wang, Lei‐Yun, et al.. (2018). Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients. OncoTargets and Therapy. Volume 11. 529–538. 13 indexed citations
19.
Cui, Jiajia, Lei‐Yun Wang, Tao Zhu, et al.. (2017). Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients. Scientific Reports. 7(1). 5082–5082. 27 indexed citations
20.
Zhu, Tao, Yuanfeng Gao, Ling Li, et al.. (2017). Aberration in translation initiation and associated diseases: Role of the eukaryotic translation initiation factor 3A.. PubMed. 42(10). 1204–1211. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026